2010
DOI: 10.2169/internalmedicine.49.3101
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Mikulicz's Disease, IgG4-related Plasmacytic Syndrome, Successfully Treated by Corticosteroid and Mizoribine, Followed by Mizoribine Alone

Abstract: We report a case of Mikulicz's disease, IgG4-related plasmacytic syndrome, successfully treated with corticosteroid and mizoribine, followed by mizoribine alone. A 56-year-old woman experienced persistent bilateral swelling in the eyelids and submandibular region accompanied by lymphadenopathy without pain. The patient was diagnosed as having Mikulicz's disease since her bilateral lacrimal glands showed persistent swelling and biopsy specimens of the submandibular glands and lymph node showed diffuse infiltrat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0
1

Year Published

2010
2010
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 14 publications
0
10
0
1
Order By: Relevance
“…Lymphadenopathy is also observed. However, reports regarding lymph node pathology of patients with IgG4-related sclerosing disease are limited, as evidenced by Table 2 [4,5,9]. In our study, we clinicopathologically reviewed three cases of IgG4-related lymphadenopathy.…”
Section: Discussionmentioning
confidence: 97%
“…Lymphadenopathy is also observed. However, reports regarding lymph node pathology of patients with IgG4-related sclerosing disease are limited, as evidenced by Table 2 [4,5,9]. In our study, we clinicopathologically reviewed three cases of IgG4-related lymphadenopathy.…”
Section: Discussionmentioning
confidence: 97%
“…In addition, maintenance therapy with steroid medication needs to be investigated. Recently, mizoribine has been used for IgG4‐related sclerosing disease and has proven to be effective for reducing symptoms and serum IgG4 levels 20. Therefore, further studies are required to more fully characterize IgG4‐related diseases in more cases and to clarify the long‐term outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Other drugs reported to be effective include azathioprine, methotrexate, mizoribine, 38 mycophenolate mofetil, cyclophosphamide, cyclosporine, bortezomib, 39 and rituximab. [40][41][42][43][44] However, their relative effectiveness and appropriateness have not yet been established.…”
Section: Other Immunomodulatory Agentsmentioning
confidence: 99%